stock
CUE · Cue Biopharma, Inc.
What Cue Biopharma, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live CUE price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CUE.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 7,264,414 as of 2026-08-12 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -262.0%
- Net
- -435.8%
Returns
- ROE
- -7104.2%
- ROA
- -534.4%
Health
- Current ratio
- 1.3x
- Debt/equity
- —
Deep value
- NCAV
- -$1.77M
- NCAV per share
- -$0.24
- Price/NCAV
- Locked
- NNWC
- -$6.97M
- NNWC per share
- -$0.96
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $7.88M | —Gross profit: unreported by this company. | -$87.69M | -$153.07M | 10-Q filed 2026-08-14 |
| 2026-03-31 | $5.69M | —Gross profit: unreported by this company. | -$5.35M | -$5.18M | 10-Q filed 2026-05-14 |
| 2025-12-31 | $21.94M | —Gross profit: unreported by this company. | $1.98M | $1.58M | 10-K filed 2026-03-16 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $2.15M | —Gross profit: unreported by this company. | -$7.59M | -$7.45M | 10-Q filed 2025-11-12 |
| 2025-06-30 | $2.95M | —Gross profit: unreported by this company. | -$8.63M | -$8.48M | 10-Q filed 2026-08-14 |
| 2025-03-31 | $421,000 | —Gross profit: unreported by this company. | -$12.30M | -$12.26M | 10-Q filed 2026-05-14 |
| 2024-12-31 | $1.58M | —Gross profit: unreported by this company. | -$9.63M | -$9.50M | 10-K filed 2026-03-16 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $3.34M | —Gross profit: unreported by this company. | -$8.81M | -$8.66M | 10-Q filed 2025-11-12 |
- Assets
- $30.71M
- Equity
- $2.31M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $27.47M | -$26.55M | -$26.60M | -$21.86M |
| 2024-12-31 | $9.29M | -$41.50M | -$40.67M | -$36.40M |
| 2023-12-31 | $5.49M | -$52.15M | -$50.73M | -$39.96M |
| 2022-12-31 | $1.25M | -$53.23M | -$53.01M | -$41.98M |
| 2021-12-31 | $14.94M | -$43.71M | -$44.16M | -$39.75M |
| 2020-12-31 | $3.15M | -$45.04M | -$44.78M | -$33.09M |
| 2019-12-31 | $3.46M | -$36.77M | -$36.70M | -$30.84M |
| 2018-12-31 | $1.14M | -$38.70M | -$38.98M | -$28.27M |
| 2017-12-31 | — | -$23.23M | -$23.23M | -$13.17M |
Company filings
since Wed Aug 12 · 2 offering filings in 12 months
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 218-KResults
ResultsAug 148-KExecutive or director change
Executive or director changeAug 38-KMaterial agreement, Unregistered share sale, Executive or director change, Other event
Material agreementUnregistered share saleExecutive or director changeOther eventJul 108-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 38-KExecutive or director change, Other event
Executive or director changeOther eventJun 28-K
5% owners ()
Shao-Lee Lin
Activist stake
DRIEHAUS CAPITAL MANAGEMENT LLC
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Ray Sumita
Chief Legal Compliance Officer
Sale$265,628Aug 17, 6:22 PM ET
Meluzio Michael Vincent
VP, Prin. Accounting Officer
Sale$169,324Aug 17, 6:19 PM ET
Lin Shao-Lee
Chief Executive Officer, Director
Sale$1,606,562Aug 14, 8:46 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named CUE, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about CUE.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on CUE come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CUE board